+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Ciclosporin"

From
From
Uveitis Drugs - Global Strategic Business Report - Product Thumbnail Image

Uveitis Drugs - Global Strategic Business Report

  • Report
  • March 2025
  • 413 Pages
  • Global
From
Organ Transplant Immunosuppressant Drugs Market Report 2025 - Product Thumbnail Image

Organ Transplant Immunosuppressant Drugs Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Ulcerative Colitis Market Report 2025 - Product Thumbnail Image

Ulcerative Colitis Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus Treatment Market Report 2025 - Product Thumbnail Image

Systemic Lupus Erythematosus Treatment Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Systemic Lupus Erythematosus Drugs Market 2025-2033 - Product Thumbnail Image

Systemic Lupus Erythematosus Drugs Market 2025-2033

  • Report
  • March 2025
  • 144 Pages
  • Global
From
From
Graft versus host disease (GvHD) - Pipeline Insight, 2024 - Product Thumbnail Image

Graft versus host disease (GvHD) - Pipeline Insight, 2024

  • Drug Pipelines
  • August 2024
  • 180 Pages
  • Global
From
Lung transplant rejection - Pipeline Insight, 2024 - Product Thumbnail Image

Lung transplant rejection - Pipeline Insight, 2024

  • Drug Pipelines
  • April 2024
  • 40 Pages
  • Global
From
Adult-Onset Still Disease - Pipeline Insight, 2024 - Product Thumbnail Image

Adult-Onset Still Disease - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 40 Pages
  • Global
From
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2024 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 80 Pages
  • Global
From
Uveitis - Pipeline Insight, 2024 - Product Thumbnail Image

Uveitis - Pipeline Insight, 2024

  • Clinical Trials
  • April 2024
  • 50 Pages
  • Global
From
Immunomodulator Market - Product Thumbnail Image

Immunomodulator Market

  • Report
  • May 2024
  • 200 Pages
  • Global
From
Psoriasis Treatment Market Report and Forecast 2024-2032 - Product Thumbnail Image

Psoriasis Treatment Market Report and Forecast 2024-2032

  • Report
  • July 2024
  • 200 Pages
  • Global
From
Loading Indicator

Ciclosporin is an immunosuppressant drug used to treat a variety of immune disorders, including rheumatoid arthritis, psoriasis, and inflammatory bowel disease. It works by suppressing the body's immune system, which helps to reduce inflammation and prevent organ rejection in transplant patients. It is also used to treat certain types of eye inflammation. Ciclosporin is available in both oral and topical formulations. Ciclosporin is a widely used drug in the treatment of immune disorders, and is often prescribed in combination with other drugs. It is generally well tolerated, with few side effects. However, it can cause serious side effects, such as high blood pressure, kidney damage, and increased risk of infection. The ciclosporin market is highly competitive, with many companies offering generic and branded versions of the drug. Some of the major players in the market include Novartis, Pfizer, Merck, and Sanofi. Other companies include Mylan, Teva, and Sandoz. Show Less Read more